Medications

US Pfizer, India's Biocon scrap insulin pact

India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.

Medications

Smarter prescriptions from doctors could save NHS billions

GP's could save billions of pounds for the NHS by switching patients' prescriptions from patented medicine to alternative drugs whose patent has expired, a new study shows. Researchers found that whilst some practitioners ...

Other

AbbVie makes $63B bid for Botox maker Allergan

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth.

Other

Novartis to buy back $5 bn in shares

Swiss pharmaceutical giant Novartis announced Wednesday a $5.0 billion share buyback even though competition from generics ate away at sales and earnings last year.

Vaccination

WHO: Vaccine hesitancy persists among Africa health workers

Africa is seeing a rise in deliveries of vaccine doses to the continent, but only one in four of its health workers has been fully vaccinated against COVID-19, the World Health Organization regional office said on Thursday.

page 9 from 20